Literature DB >> 23760624

Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry.

Ruth S Weinstock1, Dongyuan Xing, David M Maahs, Aaron Michels, Michael R Rickels, Anne L Peters, Richard M Bergenstal, Breanne Harris, Stephanie N Dubose, Kellee M Miller, Roy W Beck.   

Abstract

CONTEXT: Few studies have assessed factors associated with severe hypoglycemia (SH) and diabetic ketoacidosis (DKA) in adults with type 1 diabetes (T1D).
OBJECTIVE: Our objective was to determine frequency of and factors associated with the occurrence of SH and DKA in adults with T1D. DESIGN AND
SETTING: We conducted a cross-sectional analysis from the T1D Exchange clinic registry at 70 U.S. endocrinology centers. PATIENTS: Analysis included 7012 participants in the T1D Exchange clinic registry aged 26 to 93 years old with T1D for ≥2 years.
RESULTS: Higher frequencies of SH and DKA were associated with lower socioeconomic status (P < .001). SH was strongly associated with diabetes duration (P < .001), with 18.6% of those with diabetes ≥40 years having an event in the past 12 months. SH frequency was lowest in those with hemoglobin A1c (HbA1c) levels of 7.0% (53 mmol/mol) to 7.5% (58 mmol/mol), being higher in those with HbA1c levels <7.0% (<53 mmol/mol) or >7.5% (>58 mmol/mol). DKA frequency increased with higher HbA1c levels (P < .001), with 21.0% of those with HbA1c ≥10.0% (≥86 mmol/mol) having an event in the past 12 months.
CONCLUSIONS: SH and DKA are more common in those with lower socioeconomic status. DKA, most common in those with HbA1c ≥10.0% (≥86 mmol/mol), should be largely preventable. In contrast, SH, most frequent with diabetes ≥40 years duration, cannot be abolished given the limitation of current therapies. To reduce SH in adults with longstanding diabetes, consideration should be given to modifying HbA1c goals, particularly in patients with very low HbA1c levels.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23760624     DOI: 10.1210/jc.2013-1589

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  107 in total

1.  Management of Type 1 Diabetes in Older Adults.

Authors:  Ruban Dhaliwal; Ruth S Weinstock
Journal:  Diabetes Spectr       Date:  2014-02

2.  Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.

Authors:  Steven J Russell; Mallory A Hillard; Courtney Balliro; Kendra L Magyar; Rajendranath Selagamsetty; Manasi Sinha; Kerry Grennan; Debbie Mondesir; Laya Ekhlaspour; Hui Zheng; Edward R Damiano; Firas H El-Khatib
Journal:  Lancet Diabetes Endocrinol       Date:  2016-02-03       Impact factor: 32.069

3.  Management of Type 1 Diabetes With a Very Low-Carbohydrate Diet.

Authors:  Belinda S Lennerz; Anna Barton; Richard K Bernstein; R David Dikeman; Carrie Diulus; Sarah Hallberg; Erinn T Rhodes; Cara B Ebbeling; Eric C Westman; William S Yancy; David S Ludwig
Journal:  Pediatrics       Date:  2018-05-07       Impact factor: 7.124

4.  Association of Area Deprivation and Diabetic Ketoacidosis Readmissions: Comparative Risk Analysis of Adults vs Children With Type 1 Diabetes.

Authors:  Estelle Everett; Nestoras Mathioudakis
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

Review 5.  Reporting Severe Hypoglycemia in Type 1 Diabetes: Facts and Pitfalls.

Authors:  Ulrik Pedersen-Bjergaard; Birger Thorsteinsson
Journal:  Curr Diab Rep       Date:  2017-10-28       Impact factor: 4.810

6.  Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.

Authors:  Jenny E Blau; Sri Harsha Tella; Simeon I Taylor; Kristina I Rother
Journal:  Diabetes Metab Res Rev       Date:  2017-09-29       Impact factor: 4.876

7.  Recurrent hospitalizations for severe hypoglycemia and hyperglycemia among U.S. adults with diabetes.

Authors:  Rozalina G McCoy; Jeph Herrin; Kasia J Lipska; Nilay D Shah
Journal:  J Diabetes Complications       Date:  2018-04-24       Impact factor: 2.852

8.  Superior Glycemic Control With a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic Impacts.

Authors:  Mary Courtney Moore; David E Kelley; Raul C Camacho; Peter Zafian; Tian Ye; Songnian Lin; Niels C Kaarsholm; Ravi Nargund; Terri M Kelly; Margaret Van Heek; Stephen F Previs; Christopher Moyes; Marta S Smith; Ben Farmer; Phil Williams; Alan D Cherrington
Journal:  Diabetes       Date:  2018-03-14       Impact factor: 9.461

9.  Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes.

Authors:  Darrell M Wilson; Peter M Calhoun; David M Maahs; H Peter Chase; Laurel Messer; Bruce A Buckingham; Tandy Aye; Paula K Clinton; Irene Hramiak; Craig Kollman; Roy W Beck
Journal:  Diabetes Technol Ther       Date:  2015-03-11       Impact factor: 6.118

10.  Outpatient glycemic control with a bionic pancreas in type 1 diabetes.

Authors:  Steven J Russell; Firas H El-Khatib; Manasi Sinha; Kendra L Magyar; Katherine McKeon; Laura G Goergen; Courtney Balliro; Mallory A Hillard; David M Nathan; Edward R Damiano
Journal:  N Engl J Med       Date:  2014-06-15       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.